MyPeptide sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
By proceeding you affirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration.

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide fragment derived from human gastric juice protein BPC. It is among the most studied research peptides in preclinical models of tissue repair, angiogenesis, and gastrointestinal mucosal protection.
For laboratory and research use only. Not for human or veterinary use.
Preclinical studies suggest BPC-157 modulates growth factor expression (VEGF, FGF), promotes angiogenesis, interacts with the nitric oxide system, and stabilizes the gastric mucosal barrier. Research models include tendon transection, muscle crush injury, and inflammatory bowel models.
| sequence | GEPPPGKPADDAGLV (15 amino acids) |
| molecular Weight | 1419.53 Da |
| cas | 137525-51-0 |
| appearance | White to off-white lyophilized powder |
Reconstitute with bacteriostatic water under sterile laboratory conditions. Typical research preparations use 1–2 mL per 5 mg vial. Swirl gently — do not shake vigorously. Allow complete dissolution before use in assays.
Lyophilized: stable at room temperature for shipping; store at 2–8 °C for long-term retention. Reconstituted: refrigerate at 2–8 °C; use within laboratory-validated stability window. Protect from light.
Every lot undergoes independent third-party HPLC purity analysis, mass spectrometry identity confirmation, and endotoxin testing (<0.5 EU/mg). Certificate of Analysis (COA) is stored against the SKU lot number and available through your research account portal.